Federated Hermes (FHI) Form 144 for 707-share stock sale
Rhea-AI Filing Summary
A holder of Federated Hermes (FHI) stock has filed a Form 144 to sell 707 shares of common stock through Morgan Stanley Smith Barney LLC on or about 11/19/2025 on the NYSE. The filing lists an aggregate market value of $33,833.91 for these shares and notes that 77,537,867 shares of this class were outstanding. The securities being sold were acquired on 11/19/2025 as restricted stock vesting under a registered plan, with the consideration described as services rendered. The signer represents that they are not aware of any undisclosed material adverse information about the issuer’s current or prospective operations.
Positive
- None.
Negative
- None.
FAQ
What does the FHI Form 144 filing disclose?
The Form 144 discloses a planned sale of 707 shares of Federated Hermes (FHI) common stock by or through a broker, with the shares acquired via restricted stock vesting under a registered plan.
How many FHI shares are planned to be sold under this Form 144?
The notice covers a proposed sale of 707 shares of common stock of the issuer.
What is the aggregate market value of the FHI shares to be sold?
The filing reports an aggregate market value of $33,833.91 for the 707 shares to be sold.
How many FHI shares of this class are outstanding?
The Form 144 states that there are 77,537,867 shares of common stock outstanding for this class of securities.
When and how were the FHI shares being sold acquired?
The shares were acquired on 11/19/2025 as restricted stock vesting under a registered plan, with the consideration categorized as services rendered.
Which broker is handling the planned sale of FHI shares?
The broker named in the filing is Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004.
On which exchange are the FHI shares expected to be sold and on what date?
The Form 144 lists the NYSE as the securities exchange and gives an approximate sale date of 11/19/2025.